Recent studies and projects from 2026 focus on risk screenings, protein stability, and inflammatory processes in the brain.
Systematic Prevention Among Older Patients
The ReduRisk project at the University Hospital Freiburg has made significant strides in the clinical care of elderly individuals. A study involving 589 high-risk patients revealed that a structured risk screening for individuals over 70 significantly reduces the risk of long-term consequences.
This approach includes delirium prevention, mobility training, specialized medication counseling, and comprehensive care planning. The program not only improves daily activities and mobility upon discharge but also shows positive effects on cognitive performance after six months. Importantly, costs for hospitals remained stable. The findings have been forwarded to the German Hospital Association (DKG) to explore broader applications.
New Method for Measuring Protein Stability in Cells
In parallel to clinical initiatives, fundamental research is providing new insights into neurodegenerative diseases. Researchers at Ruhr University Bochum introduced a novel method called “confocal Fast Relaxation Imaging” (cFReI) on July 16, 2026, which allows for the direct measurement of protein stability in different cell areas.
As science finds new ways to measure protein stability, you can take proactive steps to support your mental fitness in daily life. This free guide offers 11 practical exercises to strengthen your concentration and specifically prevent dementia. These 11 everyday exercises keep your brain fit into old age
The insights gained are crucial for understanding protein clumping, as seen in Alzheimer’s and Parkinson’s diseases. Research focuses on membraneless organelles where proteins can lose their structure. Precise observation of these processes is essential for future therapies aimed at halting cognitive decline at the cellular level.
Inflammatory Processes Post-Stroke
A team from the University Hospital Würzburg published findings in 2026 in Cell Reports Medicine regarding the NLRP3 inflammasome. According to the study, this inflammatory platform becomes active immediately after a vessel occlusion in the brain.
Experimental data suggest that blocking this inflammasome may slow the progression of infarctions. Increased levels of relevant immune cells have been detected in patients with ischemic stroke. Experts are discussing the early use of NLRP3 inhibitors—potentially even in the ambulance—to minimize neuronal damage.
Since inflammatory processes play a central role in neurological damage, lifestyle prevention is gaining importance. Discover in this free expert test if your body is already showing signs of silent inflammation, and learn about the 12 most effective natural inflammation killers. Self-test: Is your body secretly suffering from inflammation?
Anti-Tau Substances: Success Only with Low Doses
In Alzheimer’s treatment, various approaches to reducing tau fibrils are currently being tested in Phase-2 studies. A study using the compound Ceperognastat on 326 patients over 100 weeks showed a reduction in fibrils and brain volume loss, but no measurable clinical benefit.
In contrast, a large-scale study with Diranersen involving 10,200 patients demonstrated a reduction of tau fibrils in cerebrospinal fluid by 50 to 65 percent. Cognitive decline slowed by 26 to 42 percent—however, this effect was observed only at the lowest dosage. Experts emphasize that the timing of treatment and possible combinations with therapies against amyloid deposits could be crucial.
Economic Challenges in Healthcare Provision
While research is advancing, practical healthcare provision faces economic challenges. The Marienhospital Stuttgart is required to close its pain clinic by August 31, 2026, due to economic reasons. Existing patients will continue to be cared for until that date, with no new admissions. This step underscores the tensions between medical necessity and the financial viability of specialized departments.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendations. Information on prices, companies, and markets without guarantee; changes may occur at any time. Trading in stocks can lead to significant losses. Our contributions are created and reviewed, partially or entirely, with AI assistance.
